Difference between revisions of "Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5 (Q9913)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 786-798, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Greiner DL, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Greiner DL | ||
| Property / Fourth Author string: Greiner DL / rank | |||
| + | Normal rank | ||
Latest revision as of 13:50, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Shultz LD
0 references
Brehm MA
0 references
Garcia-Martinez JV
0 references
2012
0 references
Nat. Rev. Immunol.
0 references
12
0 references
Humanized mice for immune system investigation: progress promise and challenges (English)
0 references
786-798
0 references
Greiner DL
0 references
